Trending Now
BUSINESS
U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01...
Cellectis a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced that the MELANI-01 trial has been placed...
MEDICAL DEVICES
MANUFACTURING
MilliporeSigma Becomes the First to Use Acoustic Technology for Cell Therapy...
MilliporeSigma today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, developer of a unique acoustic cell processing platform
MilliporeSigma today announced it has...
DON'T MISS
JOURNAL SPOTLIGHT
Stem cell biologist at Harvard retracts diabetes breakthrough manuscript published in...
A diabetes breakthrough manuscript published by Douglas A. Melton, PhD, Co-Director of Harvard Stem Cell Institute (Ref: Cell 153, 747–758; May 9, 2013)
In this article,...
EVEN MORE NEWS
